Page last updated: 2024-08-24

eticlopride and Schizophrenia

eticlopride has been researched along with Schizophrenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bezerra, EM; Caetano, EW; da Costa, RF; Freire, VN; Gottfried, C; Martins, A; Nunes, G; Zanatta, G1
De Luca, MA; Emanuele, M; Managò, F; Mastrogiacomo, R; Mastwal, S; Mereu, M; Papaleo, F; Scheggia, D; Wang, KH; Weinberger, DR1

Other Studies

2 other study(ies) available for eticlopride and Schizophrenia

ArticleYear
Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.
    ACS chemical neuroscience, 2014, Oct-15, Volume: 5, Issue:10

    Topics: Antipsychotic Agents; Dopamine Antagonists; Haloperidol; Humans; Models, Chemical; Molecular Docking Simulation; Quantum Theory; Receptors, Dopamine D3; Salicylamides; Schizophrenia; Static Electricity

2014
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.
    Cell reports, 2016, 08-23, Volume: 16, Issue:8

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Cognitive Dysfunction; Corpus Striatum; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Gene Expression; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Phenotype; Prefrontal Cortex; Psychomotor Disorders; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Sensory Gating; Synaptic Transmission

2016